2024 HCPCS Code Q5128
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
| Short Description | Inj, cimerli, 0.1 mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 01, 2023 |
| HCPCS Code Added Date | April 01, 2023 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q4038 - Cast sup shrt leg fiberglass
- Q4039 - Cast sup shrt leg ped plster
- Q4040 - Cast sup shrt leg ped fbrgls
- Q4041 - Cast sup lng leg splnt plstr
- Q4042 - Cast sup lng leg splnt fbrgl
- Q4043 - Cast sup lng leg splnt ped p
- Q4044 - Cast sup lng leg splnt ped f
- Q4045 - Cast sup sht leg splnt plstr
- Q4046 - Cast sup sht leg splnt fbrgl
- Q4047 - Cast sup sht leg splnt ped p
- Q4048 - Cast sup sht leg splnt ped f
- Q4049 - Finger splint, static
- Q4050 - Cast supplies unlisted
- Q4051 - Splint supplies misc
- Q4074 - Iloprost non-comp unit dose
- Q4081 - Epoetin alfa, 100 units esrd
- Q4082 - Drug/bio noc part b drug cap
- Q4100 - Skin substitute, nos
- Q4101 - Apligraf
- Q4102 - Oasis wound matrix